4//SEC Filing
Parikh Shamik J 4
Accession 0001818382-22-000023
CIK 0001818382other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:40 PM ET
Size
5.4 KB
Accession
0001818382-22-000023
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Parikh Shamik J
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2022-04-04+144,927→ 144,927 totalExercise: $6.90From: 2023-04-04Exp: 2032-04-04→ Common Stock (144,927 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on April 4, 2023, after which 1/48 of the option will become exercisable on the 4th of each month through August 4, 2026.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001916853
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:40 PM ET
- Size
- 5.4 KB